« Back Journal of Dermatological Science

Article in Press

Living skin equivalents constructed using human amnions as a matrix

Received 17 July 2009 ,Revised 24 September 2009 ,Accepted 24 September 2009. Published online 12 July 2010 Corrected Proof

References 

  1. Waymack P, Duff RG, Sabolinski M. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. The Apligraf Burn Study Group. Burns. 2000;26:609–619
  2. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol. 1998;134:293–300
  3. Kirsner RS. The use of Apligraf in acute wounds. J Dermatol. 1998;25:805–811
  4. Andriani F, Margulis A, Lin N, Griffey S, Garlick JA. Analysis of microenvironmental factors contributing to basement membrane assembly and normalized epidermal phenotype. J Invest Dermatol. 2003;120:923–931
  5. Jean J, Lapointe M, Soucy J, Pouliot R. Development of an in vitro psoriatic skin model by tissue engineering. J Dermatol Sci. 2009;53:19–25
  6. Wang X, Liu Y, Deng Z, Dong R, Liu Y, Hu S, et al. Inhibition of dermal fibrosis in self-assembled skin equivalents by undifferentiated keratinocytes. J Dermatol Sci. 2009;53:103–111
  7. Meana A, Iglesias J, Del Rio M, Larcher F, Madrigal B, Fresno MF, et al. Large surface of cultured human epithelium obtained on a dermal matrix based on live fibroblast-containing fibrin gels. Burns. 1998;24:621–630
  8. Llames SG, Del Rio M, Larcher F, Garcia E, Garcia M, Escamez MJ, et al. Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Transplantation. 2004;77:350–355
  9. Medalie DA, Eming SA, Collins ME, Tompkins RG, Yarmush ML, Morgan JR. Differences in dermal analogs influence subsequent pigmentation, epidermal differentiation, basement membrane, and rete ridge formation of transplanted composite skin grafts. Transplantation. 1997;64:454–465
  10. Guerret S, Govignon E, Hartmann DJ, Ronfard V. Long-term remodeling of a bilayered living human skin equivalent (Apligraf) grafted onto nude mice: immunolocalization of human cells and characterization of extracellular matrix. Wound Repair Regen. 2003;11:35–45
  11. Ojeh NO, Frame JD, Navsaria HA. In vitro characterization of an artificial dermal scaffold. Tissue Eng. 2001;7:457–472
  12. Morykwas MJ, Thornton JW, Bartlett RH. Zeta potential of synthetic and biological skin substitutes: effects on initial adherence. Plast Reconstr Surg. 1987;79:732–739
  13. Ravishanker R, Bath AS, Roy R. “Amnion Bank”—the use of long term glycerol preserved amniotic membranes in the management of superficial and superficial partial thickness burns. Burns. 2003;29:369–374
  14. Gajiwala K, Gajiwala AL. Evaluation of lyophilised, gamma-irradiated amnion as a biological dressing. Cell Tissue Bank. 2004;5:73–80
  15. Quinby WC, Hoover HC, Scheflan M, Walters PT, Slavin SA, Bondoc CC. Clinical trials of amniotic membranes in burn wound care. Plast Reconstr Surg. 1982;70:711–717
  16. Park M, Kim S, Kim IS, Son D. Healing of a porcine burn wound dressed with human and bovine amniotic membranes. Wound Repair Regen. 2008;16:520–528
  17. Mohammadi A, Johari HG. Amniotic membrane: a skin graft fixator convenient for both patient and surgeon. Burns. 2008;34:1051–1052
  18. Oyama N, Bhogal BS, Carrington P, Gratian MJ, Black MM. Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting. Br J Dermatol. 2003;148:939–944
  19. Koizumi N, Fullwood NJ, Bairaktaris G, Inatomi T, Kinoshita S, Quantock AJ. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci. 2000;41:2506–2513
  20. Nakamura T, Endo K, Cooper LJ, Fullwood NJ, Tanifuji N, Tsuzuki M, et al. The successful culture and autologous transplantation of rabbit oral mucosal epithelial cells on amniotic membrane. Invest Ophthalmol Vis Sci. 2003;44:106–116
  21. Sakamoto T, Hirano K, Morishima Y, Masuyama K, Ishii Y, Nomura A, et al. Maintenance of the differentiated type II cell characteristics by culture on an acellular human amnion membrane. In Vitro Cell Dev Biol Anim. 2001;37:471–479
  22. Espana EM, He H, Kawakita T, Di Pascuale MA, Raju VK, Liu CY, et al. Human keratocytes cultured on amniotic membrane stroma preserve morphology and express keratocan. Invest Ophthalmol Vis Sci. 2003;44:5136–5141
  23. Kumar TR, Shanmugasundaram N, Babu M. Biocompatible collagen scaffolds from a human amniotic membrane: physicochemical and in vitro culture characteristics. J Biomater Sci Polym Ed. 2003;14:689–706
  24. Kubo M, Sonoda Y, Muramatsu R, Usui M. Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci. 2001;42:1539–1546
  25. Solomon A, Wajngarten M, Alviano F, Anteby I, Elchalal U, Pe’er J, et al. Suppression of inflammatory and fibrotic responses in allergic inflammation by the amniotic membrane stromal matrix. Clin Exp Allergy. 2005;35:941–948
  26. Burman S, Tejwani S, Vemuganti GK, Gopinathan U, Sangwan VS. Ophthalmic applications of preserved human amniotic membrane: a review of current indications. Cell Tissue Bank. 2004;5:161–175
  27. von Versen-Hoynck F, Syring C, Bachmann S, Moller DE. The influence of different preservation and sterilisation steps on the histological properties of amnion allografts—light and scanning electron microscopic studies. Cell Tissue Bank. 2004;5:45–56
  28. Rejzek A, Weyer F, Eichberger R, Gebhart W. Physical changes of amniotic membranes through glycerolization for the use as an epidermal substitute. Light and electron microscopic studies. Cell Tissue Bank. 2001;2:95–102
  29. von Versen-Hoeynck F, Steinfeld AP, Becker J, Hermel M, Rath W, Hesselbarth U. Sterilization and preservation influence the biophysical properties of human amnion grafts. Biologicals. 2008;36:248–255
  30. Shirakata Y, Ueno H, Hanakawa Y, Kameda K, Yamasaki K, Tokumaru S, et al. TGF-beta is not involved in early phase growth inhibition of keratinocytes by 1alpha,25(OH)2vitamin D3. J Dermatol Sci. 2004;36:41–50
  31. Shirakata Y, Tokumaru S, Yamasaki K, Sayama K, Hashimoto K. So-called biological dressing effects of cultured epidermal sheets are mediated by the production of EGF family, TGF-beta and VEGF. J Dermatol Sci. 2003;32:209–215
  32. Yang L, Shirakata Y, Shudou M, Dai X, Tokumaru S, Hirakawa S, et al. New skin-equivalent model from de-epithelialized amnion membrane. Cell Tissue Res. 2006;326:69–77
  33. Yang L, Shirakata Y, Tamai K, Dai X, Hanakawa Y, Tokumaru S, et al. Microbubble-enhanced ultrasound for gene transfer into living skin equivalents. J Dermatol Sci. 2005;40:105–114
  34. Cooper LJ, Kinoshita S, German M, Koizumi N, Nakamura T, Fullwood NJ. An investigation into the composition of amniotic membrane used for ocular surface reconstruction. Cornea. 2005;24:722–729
  35. Nakamura T, Yoshitani M, Rigby H, Fullwood NJ, Ito W, Inatomi T, et al. Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Invest Ophthalmol Vis Sci. 2004;45:93–99
  36. Woodley DT, Wynn KC, O’Keefe EJ. Type IV collagen and fibronectin enhance human keratinocyte thymidine incorporation and spreading in the absence of soluble growth factors. J Invest Dermatol. 1990;94:139–143
  37. Nishiyama T, Amano S, Tsunenaga M, Kadoya K, Takeda A, Adachi E, et al. The importance of laminin 5 in the dermal-epidermal basement membrane. J Dermatol Sci. 2000;24:S51–S59
  38. Frank DE, Carter WG. Laminin 5 deposition regulates keratinocyte polarization and persistent migration. J Cell Sci. 2004;117:1351–1363[Epub 2004 Mar 1302]
  39. Kikkawa Y, Umeda M, Miyazaki K. Marked stimulation of cell adhesion and motility by ladsin, a laminin-like scatter factor. J Biochem (Tokyo). 1994;116:862–869
  40. Kim SW, Park KC, Kim HJ, Cho KH, Chung JH, Kim KH, et al. Effects of collagen IV and laminin on the reconstruction of human oral mucosa. J Biomed Mater Res. 2001;58:108–112
  41. Ralston DR, Layton C, Dalley AJ, Boyce SG, Freedlander E, Mac Neil S. The requirement for basement membrane antigens in the production of human epidermal/dermal composites in vitro. Br J Dermatol. 1999;140:605–615
  42. Blomme EA, Weckmann MT, Capen CC, Rosol TJ. Influence of extracellular matrix macromolecules on normal human keratinocyte phenotype and parathyroid hormone-related protein secretion and expression in vitro. Exp Cell Res. 1998;238:204–215
  43. Kim JP, Chen JD, Wilke MS, Schall TJ, Woodley DT. Human keratinocyte migration on type IV collagen. Roles of heparin-binding site and alpha 2 beta 1 integrin. Lab Invest. 1994;71:401–408
  44. Erdag G, Sheridan RL. Fibroblasts improve performance of cultured composite skin substitutes on athymic mice. Burns. 2004;30:322–328
  45. El Ghalbzouri A, Ponec M. Diffusible factors released by fibroblasts support epidermal morphogenesis and deposition of basement membrane components. Wound Repair Regen. 2004;12:359–367
  46. Klein B, Schiffer R, Hafemann B, Klosterhalfen B, Zwadlo-Klarwasser G. Inflammatory response to a porcine membrane composed of fibrous collagen and elastin as dermal substitute. J Mater Sci Mater Med. 2001;12:419–424

PII: S0923-1811(09)00291-6

doi: 10.1016/j.jdermsci.2009.09.009

« Back Journal of Dermatological Science

Article in Press

Article Tools

* Image Usage & Resolution